More than a third of transactions announced in the third quarter included a party that cited financial distress as a reason behind the deal, according to the report.
Financial distress is driving health system M&A, Kaufman Hall reports Read More »
Physicians accounted for nearly half of departures from 2021 through 2022, with staffing shortages putting care quality at risk, according to a new report from Definitive Healthcare.
Healthcare worker exodus continued through 2022, new data shows Read More »
The FDA previously alerted healthcare providers to the potential for neonatal incubators to emit airborne chemicals.
GE HealthCare cuts formaldehyde levels in neonatal incubators with revised process Read More »
Servier, a global independent pharmaceutical group, and Owkin, a French American biotech focused on applying artificial intelligence (AI) to drug discovery,
TeselaGen Biotechnology Inc., the software company providing an all-in-one platform for seamless, scalable biotech R&D, announces the acquisition of two cutting-edge patents that advance AI-driven optimization of biological phenotypes.
La cirugía íntima femenina ha experimentado un auge en las últimas décadas, impulsada tanto por razones estéticas como funcionales. Entre las intervenciones más populares se encuentran la labioplastia y la vaginoplastia. Aunque ambas pertenecen al ámb …
Labioplastia y otras cirugías íntimas femeninas: una perspectiva médica y estética Read More »
En el vasto escenario cósmico, la Tierra tiene un destino inevitable: la destrucción. Aunque este desenlace no ocurrirá en un futuro cercano, la transformación del Sol en una estrella gigante roja es una realidad que el planeta enfrentará en unos miles de millones …
Así será destruida la Tierra, y no hay nada que podamos hacer al respecto Read More »
Merck, known as MSD outside of the United States and Canada, announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of PREVYMIS® for prophylaxis of cytomegalovirus disease in adult kidney transplant recipients at high risk.
Diakonos Oncology Corporation, a clinical stage immuno-oncology company, announced that the U.S. Food and Drug Administration has granted Fast Track designation for the Company’s unique dendritic cell vaccine, DOC1021.
Saphetor SA announce that it is partnering with world-leading healthcare intelligence and clinical research organisation ICON to develop an innovative approach to support the planning and execution of clinical trials in the precision medicine and rare diseases space.
